2,6-Dimethyl-5-methoxycarbonyl-4-(3-nitrophenyl)-1,4-dihydorpyridine-3-carboxylicacid CAS:74936-72-4

2,6-Dimethyl-5-methoxycarbonyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid has shown promise in preclinical research as a potential candidate for cardiovascular disorders such as hypertension. Its mechanism of action involves blocking calcium channels in blood vessels, leading to vasodilation and reduced peripheral vascular resistance, which can help lower blood pressure. Studies on 2,6-Dimethyl-5-methoxycarbonyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid have also suggested its possible role in other cardiovascular conditions, including angina pectoris and certain arrhythmias. By modulating calcium influx into cardiac and smooth muscle cells, this compound may have anti-ischemic and antiarrhythmic effects that could benefit patients with these conditions. Furthermore, the unique structural features of 2,6-Dimethyl-5-methoxycarbonyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid make it a target for medicinal chemistry research aimed at developing more potent and selective calcium channel blockers with improved therapeutic profiles. Its chemical structure allows for modifications that can enhance its pharmacokinetic properties and optimize its efficacy in treating cardiovascular diseases. While further clinical studies are needed to validate the safety and efficacy of 2,6-Dimethyl-5-methoxycarbonyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid in humans, the preliminary research suggests that it holds promise as a novel therapeutic agent for cardiovascular disorders. Collaborative efforts between researchers, pharmaceutical companies, and regulatory agencies will be essential in advancing the development of this compound towards potential clinical use. In summary, 2,6-Dimethyl-5-methoxycarbonyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid represents a new avenue in cardiovascular drug discovery, offering a unique pharmacological profile that may address unmet medical needs in the management of hypertension, angina, and arrhythmias. Continued research and development efforts will be crucial in unlocking the full therapeutic potential of this compound and bringing innovative treatment options to patients with cardiovascular diseases.